• Home
  • Sector News
    • Technology
    • Energy
    • Financial Services
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report

Subscribe to stay informed!

Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

What's Hot

Update on September Covered Calls Trades on Dividend Stocks

September 23, 2023

September Correction: 5 Hints of a Turnaround

September 23, 2023

Hawaiian Electric Industries, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Hawaiian Electric Industries, Inc. of Deadline in Securities Fraud Class Action Lawsuit

September 23, 2023
Telegram RSS
  • Government
  • Press Releases
  • Stock Market
  • Top Stories
  • Trading Insights
  • Trending
  • About Us
Telegram RSS
Virtus Junxit EquitiesVirtus Junxit Equities
  • Home
  • Sector News
    1. Technology
    2. Energy
    3. Financial Services
    4. View All

    Global LASIK Eye Surgery Devices Market Analysis Report 2023-2028: Medical Tourism and LASIK Surgery as the Preferred Treatment for Refractive Errors Bolsters Growth

    September 23, 2023

    African leaders sound the alarm on a deadly malaria emergency and call for urgent action to address a significant funding shortfall

    September 23, 2023

    From AI to Patient Advocacy: The Comprehensive Orphan Drugs and Rare Diseases Conference: London, United Kingdom – October 9-10, 2023

    September 23, 2023

    Overwhelming Majority of College Students Value Free Expression, Yet Almost Half Fear Sharing Their Views

    September 23, 2023

    Strategy: Long Chicago Wheat Butterfly Spread and Short RBOB Gasoline Calendar Spread

    September 23, 2023

    Ammonia Crackers: Powering a Greener Future with Hydrogen – Market Set to Reach $1,574.44 Million by 2032

    September 23, 2023

    Are Wheat, Corn, and Soybeans Being Sold off Excessively in Grain Markets?

    September 23, 2023

    Analysis Report on the Global Polybutadiene Industry 2023-2028: Increasing Demand Driven by Construction Boom and Advancements in the Automotive Industry

    September 23, 2023

    Update on September Covered Calls Trades on Dividend Stocks

    September 23, 2023

    Hawaiian Electric Industries, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Hawaiian Electric Industries, Inc. of Deadline in Securities Fraud Class Action Lawsuit

    September 23, 2023

    Update #4: September Puts Options Trades

    September 23, 2023

    Will Warmer Weather in Australia Lead to Higher Profits for Australian Dollar Traders?

    September 23, 2023

    Update on September Covered Calls Trades on Dividend Stocks

    September 23, 2023

    September Correction: 5 Hints of a Turnaround

    September 23, 2023

    Hawaiian Electric Industries, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Hawaiian Electric Industries, Inc. of Deadline in Securities Fraud Class Action Lawsuit

    September 23, 2023

    Update #4: September Puts Options Trades

    September 23, 2023
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report
Get Access
Virtus Junxit EquitiesVirtus Junxit Equities
Home»Trading Insights»Newmont’s Newcrest Deal Advances With Regulatory Approvals
Trading Insights

Newmont’s Newcrest Deal Advances With Regulatory Approvals

James TaylorBy James TaylorSeptember 19, 2023Updated:September 19, 2023No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Newmont Corporation (NEM) has received regulatory clearance from Australia’s Foreign Investment Review Board (FIRB) and Japan’s Fair Trade Commission (JFTC) for its proposed acquisition of Newcrest Mining Limited. The completion of the transaction is expected to proceed after September 30, 2023, following the JFTC clearance.

Newmont is actively seeking other necessary regulatory approvals and aims to finalize the acquisition in the fourth quarter of this year. The Australian Competition & Consumer Commission has already approved the acquisition, and the remaining pending approval is from the Philippine Competition Commission (PCC). Newmont and Newcrest are also in discussions with the PNG Government and regulators to secure further approvals for the transaction.

Newmont’s President and CEO, Tom Palmer, expressed satisfaction with the regulatory approvals in Australia and Japan. He stated that this acquisition will strengthen Newmont’s operational presence and establish Australia as a significant center for its global business, attracting shareholders from Australia and the Asia Pacific region.

Newmont Corporation Price and Consensus

Image: Newmont Corporation Price and Consensus

The acquisition, announced on May 14, will combine a world-class portfolio of assets, focusing on Tier 1 operations in low-risk mining jurisdictions. The combined entity will have a substantial production profile from ten large, long-life, cost-effective Tier 1 operations, with increased annual copper production primarily from Australia and Canada. The merger is expected to generate annual pre-tax synergies of $500 million within the first 24 months and target at least $2 billion in cash improvements through portfolio optimization in the initial two years post-closure.

Newmont’s shares have fallen 8.6% in the past year compared to the industry’s 17.5% rise during the same period.

Zacks Rank & Key Picks

Newmont currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the basic materials space are Carpenter Technology Corporation (CRS) and Akzo Nobel N.V. (AKZOY), both with a Zacks Rank #1 (Strong Buy), and Alamos Gold Inc. (AGI), carrying a Zacks Rank #2 (Buy).

For more information and stock analysis reports:

– Newmont Corporation (NEM) : Free Stock Analysis Report

– Carpenter Technology Corporation (CRS) : Free Stock Analysis Report

– Akzo Nobel NV (AKZOY) : Free Stock Analysis Report

– Alamos Gold Inc. (AGI) : Free Stock Analysis Report

Disclaimer: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleWells Fargo’s Preferred Stock, Series Y Yield Surpasses 6%
Next Article Citigroup has started covering Arrowhead Pharmaceuticals (ARWR) and has given it a neutral recommendation, according to Fintel. This initiation of coverage took place on September 19, 2023. The average price target for Arrowhead Pharmaceuticals as of August 31, 2023, is $59.71, with forecasts ranging from $27.27 to $94.50. This suggests a potential upside of 112.26% from the latest reported closing price of $28.13. Arrowhead Pharmaceuticals is projected to have annual revenue of $309 million, representing an increase of 20.76%. The projected annual non-GAAP EPS is -1.78. There are currently 591 funds or institutions reporting positions in Arrowhead Pharmaceuticals, which is an increase of 15 owners or 2.60% in the last quarter. The average portfolio weight of all funds dedicated to ARWR is 0.21%, indicating an increase of 18.22%. Institutions’ total shares owned decreased by 3.19% in the last three months to 79,636K shares. The put/call ratio of ARWR is 0.32, suggesting a bullish outlook. In terms of other shareholders, iShares Core S&P Mid-Cap ETF (IJH) holds 3,243K shares, representing 3.03% ownership of the company. This is a decrease of 3.04% compared to its previous filing. Vanguard Total Stock Market Index Fund Investor Shares (VTSMX) holds 3,227K shares, representing 3.01% ownership, indicating an increase of 0.33%. Jpmorgan Chase holds 2,881K shares, representing 2.69% ownership, which is a decrease of 1.01%. Vanguard Small-Cap Index Fund Investor Shares (NAESX) holds 2,622K shares, representing 2.45% ownership, with a decrease of 2.73%. iShares Russell 2000 ETF (IWM) holds 2,322K shares, representing 2.17% ownership, indicating an increase of 3.84%. Arrowhead Pharmaceuticals develops RNA-based medicines that target genes causing intractable diseases. Their therapies utilize RNA interference (RNAi) to silence specific genes and affect protein production. RNAi is a natural mechanism present in living cells that inhibits gene expression. This pathway of gene silencing is the foundation of Arrowhead’s RNAi-based therapeutics. Fintel is an investing research platform that provides comprehensive data to individual investors, traders, financial advisors, and small hedge funds. Their data includes fundamentals, analyst reports, ownership data, fund sentiment, insider trading, options flow, unusual options trades, and more. Their stock picks are powered by advanced, backtested quantitative models for improved profits. For further information, you can visit Fintel’s website. Please note that the views and opinions expressed in this article are those of the author and do not necessarily reflect those of Nasdaq, Inc.
James Taylor
  • Website
  • X (Twitter)

A writer and finance enthusiast who loves diving into the exciting world of stocks, commodities, forex, and crypto. I'm all about making the financial markets less intimidating and more accessible, so I write engaging content that simplifies complex concepts and shares practical investment strategies. Whether you're a seasoned investor or just getting started, I've got your back! But hey, life isn't all about work, right? On weekends, you'll find me hanging out and having a blast with my awesome friends and family. We love bonding over shared interests, trying out new adventures, and simply enjoying each other's company. Striking that balance between work and play is super important to me, because what's the point of success if you can't share it with the people you love? So, if you're up for some financial market insights and a good dose of weekend fun, stick around! Together, we'll navigate the money world and make the most of our time off. Let's learn, grow, and create memories along the way!

Related Posts

Shiba Inu Spikes Sharply On Rising Volume: What’s Going On

September 23, 2023By James Taylor0

Palantir, Instacart, Bitcoin And Why UAW Strike Is A Win For Tesla: Benzinga Bulls And Bears

September 23, 2023By James Taylor0

Here’s When You Can Watch Netflix’s ‘Squid Game’ Reality Show And How Much The Record Prize Is – Netflix (NASDAQ:NFLX)

September 23, 2023By James Taylor0

Leave A Reply Cancel Reply

Our Picks
Financial Services

Update on September Covered Calls Trades on Dividend Stocks

By James TaylorSeptember 23, 2023
Financial Services

Hawaiian Electric Industries, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Hawaiian Electric Industries, Inc. of Deadline in Securities Fraud Class Action Lawsuit

By James TaylorSeptember 23, 2023
Financial Services

Update #4: September Puts Options Trades

By James TaylorSeptember 23, 2023
Technology

Global LASIK Eye Surgery Devices Market Analysis Report 2023-2028: Medical Tourism and LASIK Surgery as the Preferred Treatment for Refractive Errors Bolsters Growth

By James TaylorSeptember 23, 2023
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Stock Market

September Correction: 5 Hints of a Turnaround

By James TaylorSeptember 23, 2023

Corrections are Normal Various factors, including economic data, geopolitical events, central bank policy, investor sentiment, or simple shifts in supply and demand for equities can trigger corrections. Often, in robust bull markets, investors can forget that corrections serve as a natural part of the market’s cycle. Did you know that…

9 Red Flags To Watch Out For When Buying a Used Car

September 23, 2023

Can Warmer Weather Increase Australian Dollar Trader Profits?

September 23, 2023

Guggenheim Reiterates Immunovant (IMVT) Buy Recommendation

September 23, 2023
FEATURED INSIGHTS​
Financial Services

Update on September Covered Calls Trades on Dividend Stocks

By James TaylorSeptember 23, 2023
Stock Market

September Correction: 5 Hints of a Turnaround

By James TaylorSeptember 23, 2023
Financial Services

Hawaiian Electric Industries, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Hawaiian Electric Industries, Inc. of Deadline in Securities Fraud Class Action Lawsuit

By James TaylorSeptember 23, 2023

Subscribe to stay informed!

Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

Telegram RSS
  • Home
  • Privacy Policy
  • Disclaimer
  • Virtus Report
  • Get Access
  • About Us
© 2023 Virtus Junxit LLC

Type above and press Enter to search. Press Esc to cancel.